Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116353022 | 11635302 | 2 | F | 2011 | 20150914 | 20151015 | 20160912 | PER | US-GLENMARK PHARMACEUTICALS INC, USA.-2015GMK018535 | GLENMARK | 0.00 | Y | 0.00000 | 20160912 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116353022 | 11635302 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 600 MG, TID | U | 77662 | 600 | MG | TABLET | TID | |||||
| 116353022 | 11635302 | 2 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 60 MG, QD | 0 | 60 | MG | TABLET | |||||||
| 116353022 | 11635302 | 3 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 25 MG, QD, HALF TABLET | 0 | 25 | MG | TABLET | |||||||
| 116353022 | 11635302 | 4 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 10 MG, QD | 0 | 10 | MG | TABLET | |||||||
| 116353022 | 11635302 | 5 | C | FISH OIL W/VITAMIN D NOS | 2 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116353022 | 11635302 | 1 | Neuropathy peripheral |
| 116353022 | 11635302 | 2 | Affective disorder |
| 116353022 | 11635302 | 3 | Blood pressure measurement |
| 116353022 | 11635302 | 4 | Blood pressure measurement |
| 116353022 | 11635302 | 5 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116353022 | 11635302 | Drug ineffective for unapproved indication | |
| 116353022 | 11635302 | Product substitution issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116353022 | 11635302 | 1 | 2011 | 0 |